NCT01325233View on ClinicalTrials.gov

The Pilot Clinical Study of PG2 Injection on Hemorrhagic Stroke

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Hemorrhagic Stroke
Interventions
DRUG

PG2

Powder for Injection, 500 mg PG2/500 ml normal saline, tiw, 2 weeks

DRUG

Placebo

500 ml normal saline, tiw, 2 weeks

Trial Locations (1)

40447

China Medical University Hospital, Taichung

Sponsors
All Listed Sponsors
lead

PhytoHealth Corporation

INDUSTRY